![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Estratti |
Permessi |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
ORIGINAL ARTICLES
Italian Journal of Vascular and Endovascular Surgery 2013 December;20(4):221-3
Copyright © 2013 EDIZIONI MINERVA MEDICA
lingua: Inglese
Early results of peripheral arterial performed using shelhigh no-react treated internal mammary arteries
Avşar M. K. 1, Poyrazoglu H. H. 1, Demir Ş. 2, Atli H. 3 ✉
1 Departmant of Cardiovascular Surgery Taksim German Hospital, Beyoglu, Istanbul, Turkey; 2 Department of Cardiovascular Surgery, Adana State Hospital, Adana, Turkey; 3 Cardiovascular Surgery Depertmant, Medicine Faculty Cukurova University, Adana, Turkey
In 30 cases at our clinic, bovine internal mammary arterial grafts, were used for femoro-popliteal arterial bypass on patients to be re-operated due to obstruction. All patients had previously gone through coronary bypass in the period 2009-2011, and subsequently had no saphenous veins or whose saphenous vein quality and diameter was inadequate where a Dacron® synthetic graft, autologous saphenous vein or PTFE were used. Alongside of the peripheral arterial bypass, aorta-bifemoral bypass with a Dacron® graft was performed on six patients. After the operation, all patients were monitored at week 1, week 4 and week 8 by arterial colored Doppler ultrasoundography, and MR angiography was performed at week 12 and MR angiography was performed at year 1. Early period check-ups (postoperative, week 12) and medium term follow-ups (postoperative year 1), no obstruction was detected except in 4 patient. The No-React® treated Shelhigh internal mammary artery graft may be an alternative to saphenous vein and inorganic tubular grafts for femoro-popliteal arterial bypass operations in cases where autologous veins are not available. As evidenced by the patient cohort and early period results, this alternative may be particularly useful for patients which 1) are to be reoperated due to obstruction; 2) who had gone through coronary bypass and have no saphenous veins; or 3) whose saphenous vein quality and/or diameter are inadequate where Dacron® saphenous vein or PTFE were used.